6
Views
9
CrossRef citations to date
0
Altmetric
Symposium ENT problems: OTITIS MEDIA

Otitis media reassessed

Up-to-date answers to some basic questions

Pages 73-82 | Published online: 05 Dec 2017
 

Preview

Management of otitis media in children is a controversial matter: The basic questions of why, in whom, and how it should be treated are undergoing continual reassessment. In this article, Drs Shapiro and Bluestone provide answers to these and other questions, such as Why is treatment of acute otitis media justified? When is the “wait and see” approach to otitis media with effusion inadvisable? Which common treatment approaches are ineffective? When should referral to an otolaryngologist be considered?

Additional information

Notes on contributors

Andrew M. Shapiro

Andrew M. Shapiro, MD Charles D. Bluestone, MD Dr Shapiro (pictured) is a member of the faculty and Dr Bluestone is director, department of pediatric otolaryngology, Children's Hospital of Pittsburgh. Dr Bluestone is also professor of otolaryngology, University of Pittsburgh School of Medicine.

Charles D. Bluestone

Andrew M. Shapiro, MD Charles D. Bluestone, MD Dr Shapiro (pictured) is a member of the faculty and Dr Bluestone is director, department of pediatric otolaryngology, Children's Hospital of Pittsburgh. Dr Bluestone is also professor of otolaryngology, University of Pittsburgh School of Medicine.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.